I can see the status bar

Chapter 791 Forcing the Palace

Chapter 791 Forcing the Palace
In the Tokyo Exchange, the green numbers on the screen are jumping rapidly.Unlike the Chinese stock market, most foreign stock markets are marked with green for rising and red for falling.This full screen of green is not a stock market crash, but a rising reaction.

The originally fluctuating upward index suddenly went down a bit.Of course, such small fluctuations have to occur hundreds of times a day, and it is not worth the attention of the "financial elites" present.

The index dropped sharply for a second time, and at this time, some traders began to notice the situation.They began to frown and exchange information, hoping to find out the reason for the index's decline.

The third drop suddenly appeared when traders were discussing. This time, the index directly fell by more than 1%.The sudden change in the index caused a sudden change in the situation in the market that was still green throughout the morning.The trend of the index plummeted like a snake hit by a hammer on the head.But three and 10 minutes later, the Nikkei index, which still had a 1.1% increase in the morning, gave up all its gains and fell by nearly 1%.

This level of volatility is already rare for the Nikkei Index, which has always been known for its "calmness".And when everyone finally found the source of the waves, shock once again became the main emotion in the market.

Takeda Pharmaceutical, which has risen by more than 70% in the past three years, has fallen by 16% from the previous day's transaction price, and has fallen by 17.2% from the morning high.

Takeda Pharmaceutical has a total of 15 billion outstanding shares on the Tokyo Stock Exchange, and the transaction price per share at the opening today was 6412 yen.At present, its transaction price has dropped to 5386 yen per share.

This also means that within half an hour, Takeda Pharmaceutical lost a total of 1530 billion yen in market value, which is more than 14 billion US dollars.

The loss of US$14 billion is actually not a big blow to Takeda Pharmaceutical.But this is a signal that makes all Japanese investors vigilant-Takeda Pharmaceutical is a listed company with a long history, and since the acquisition of Shire Pharmaceuticals, its annual total revenue will exceed 300 billion US dollars.Compared with its total market value of 955 billion US dollars listed in Japan, this is a very huge number.

It is precisely because of this that the stock price of Takeda Pharmaceuticals is particularly favored by investors-they all believe that, at a price of less than 4000 yen per share, Takeda Pharmaceuticals is a seriously undervalued company.If you refer to the average earnings of other pharmaceutical companies, the share price of Takeda Pharmaceuticals should rise to at least [-] yen per share.

However, the status quo, which fell by 16% in a single day, has become a wake-up call.Countless investors suddenly realized that Takeda Pharmaceutical did not seem to be as profitable as they imagined.

At the same time as Takeda Pharmaceutical's flash crash, the Nikkei Index was also brought down all the way.By the close of trading today, Takeda Pharmaceutical had fallen 34%, while the Nikkei had fallen more than 5.8%, and the circuit breaker mechanism was triggered.This range has become the fifth largest decline in history since 1990.Second only to 08% in the 11.4 subprime mortgage crisis, 9.38%, 7.3% after the Japanese earthquake, and 13% after the Bank of Japan maintained its ultra-loose monetary policy meeting in 7.

A large pharmaceutical company that has not had any negative news and is operating normally, the price on the exchange suddenly plummeted by 34%.This is shocking news.That afternoon, this piece of news almost occupied the headlines of all Japanese media.Countless investors and ordinary people are asking what caused this plunge.

An hour after the closing bell, a Takeda spokesman spoke to the media and insisted that the company's operations were normal.Whether it is the existing research and development, or the sales of drugs that have been marketed, they are proceeding according to the established process.As for the sharp fluctuations in the stock market, the spokesperson believes that some irrational factors may have appeared in the market.

At the same time, another press conference was quietly going on.Standing in the center of the venue, Yoshida Susho, a senior representative of Takeda Pharmaceuticals, said to the reporters who came to the press conference, "Chairman Kobayashi's business decision-making has a huge problem, and it has brought huge irreparable losses to the company. And Chairman Kobayashi However, he abused his status as a major shareholder and insisted on going his own way. Therefore, we decided to collectively sell the stocks we held in our hands-only a small part of the sale has been carried out so far."

After hearing this level of speech, the reporters in the audience immediately asked, "So, your company has lost the confidence of the management?"

"We believe that Chairman Kobayashi's decision will only cause the company to suffer huge losses, and at the current point in time, this loss may still be avoided." Yoshida Osamu seemed to have expected that reporters would ask such questions, and he declared Said, "We also took this opportunity to propose a motion to the board of directors - to cancel Mr. Xiao Linfeng's post as chairman. If this motion does not get the support of the board of directors, then we will sell all the shares in our hands - this The number of shares will account for 13.5% of the total share capital."

"What decision did Chairman Kobayashi make?" The reporter asked more actively, "Is it related to the acquisition of Shire Pharmaceuticals?"

"The comprehensive diagnosis center model that Chairman Kobayashi is determined to implement has not brought the expected benefits to the company, but has brought a heavy burden to the company." Yoshida Osamu said, "We have always believed that Takeda's future cannot be assured. Entrusted to Kobayashi Feng. Therefore, a decision was made."

In Japanese companies with a strict hierarchy, this kind of "lower than upper" is almost unheard of.It is a big event in any company that the executives collectively force the palace.Osamu Yoshida, who started in the sales department and was once the general manager of Greater China, has always been considered by the outside world as the most likely candidate to succeed Feng Xiaolin.Such a person suddenly organizes to force the palace, asks Kobayashi Feng to step down, and even sells all Takeda shares in his hand.The meaning here... is very intriguing.

·
·
·
"Yoshida and his gang finally showed their fangs." In the high-rise apartment in the port area, Feng Xiaolin looked at the night scene outside the window, and took a sip of the whiskey in his hand with great interest.Behind him, Kobayashi Kaoru asked with a worried expression, "Should we also respond?"

"Response? Why do you respond to the shouts of the young people who are bound to fail?" Xiao Linfeng shook his head with a smile, and continued to face out of the window and asked, "Xun, this company will definitely be yours in the future. As a future Chairman, what will you do?"

"Respond positively and let everyone know that Yoshida's accusation is not true." Kaoru Kobayashi replied after thinking for a while, "Then... narrow the support for implementing the comprehensive diagnosis center model, and release the annual report in advance."

Xiao Linfeng nodded with a smile after listening, "You are still the same as before, and you like to deal with it in this dignified way." He took another sip of whiskey, and then asked with a smile, "Do you think that according to your way of dealing with it? After the method is processed, what will be the consequences?"

This rhetorical question made Kobayashi Kaoru silent for a long time. He frowned and shook his head and said, "This may reassure other investors, but it will not change Yoshida's mind. If all the shares in his hand are sold out, It will still affect the stock price to a large extent.”

"If what you are facing is only the capital market, then this kind of response is not only no problem. At the same time, it will also earn the company a good reputation of 'valuing shareholders'." Xiao Linfeng nodded, and then said, "But you are not now In the face of capital, we are facing an individual who is malicious to us. He may not be able to bring down Takeda, but he will certainly be able to cause the company to suffer heavy losses." Having said that, Xiao Linfeng slowly turned around and said to himself His son said, "Even if Takeda goes bankrupt tomorrow, our family can continue to enjoy tens or even hundreds of years of life without worrying about food and clothing. But... what about the employees of Takeda? What about our shareholders?" His voice gradually became louder. , "We don't need to respond to Yoshida's threats, but we must take concrete actions. This move not only needs to reassure investors, but also needs to convince them that Takeda still has huge potential waiting to be discovered."

"So... what are you going to do?" This series of words made Kobayashi a little confused, "Do you need to sue them?"

"No. You need to show the results—the results that can make the public think." Xiao Linfeng finished his glass of wine and took the phone from the secretary. "It seems that it is time for Dr. Sun to reveal something to us. Good news."

 About a dozen chapters have been counted for blood donation and update, and Luo is seriously considering whether to finish it this month...

  By the way, the fan activity is still going on, please actively participate~ There are prizes to be won!
  
 
(End of this chapter)

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like